Drug Shortage Report for PMS-RABEPRAZOLE EC

Last updated on 2023-06-06 History
Report ID 166914
Drug Identification Number 02310813
Brand name PMS-RABEPRAZOLE EC
Common or Proper name RABEPRAZOLE EC
Company Name PHARMASCIENCE INC
Market Status DORMANT
Active Ingredient(s) RABEPRAZOLE SODIUM
Strength(s) 20MG
Dosage form(s) TABLET (ENTERIC-COATED)
Route of administration ORAL ORAL
Packaging size 100
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-08-17
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2023-06-06
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2023-06-06 French Compare
v4 2023-06-06 English Compare
v3 2022-08-18 English Compare
v2 2022-08-17 French Compare
v1 2022-08-17 English Compare

Showing 1 to 5 of 5